Based on the results reported here, we postulate that the levels of Cav-1 and MnSOD expression are determinant to metabolic changes that support tumor progression and that the Cav-1low/MnSODhigh phenotype indicates a subgroup of aggressive types of breast cancer with poorer prognosis. Here, SOD2 is linked to breast carcinoma.